Amanote Research

Amanote Research

    RegisterSign In

Venetoclax Is an Option in B‐cell Prolymphocytic Leukaemia Following Progression on B‐cell Receptor Pathway Inhibitors

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15912
Full Text
Open PDF
Abstract

Available in full text

Categories
Hematology
Date

April 2, 2019

Authors
Nikila PatilRichard G. Went
Publisher

Wiley


Related search

Triradial and Quadriradial Chromosomes Detected in a Case of B-Cell Prolymphocytic Leukaemia

British Journal of Haematology
Hematology
2017English

ATM Is Usually Rearranged in T-Cell Prolymphocytic Leukaemia

Oncogene
Cancer ResearchGeneticsMolecular Biology
1998English

B-Cell Prolymphocytic Leukemia Has 3 Subsets

Blood
BiochemistryImmunologyCell BiologyHematology
2019English

Auer Rod-Like Inclusions in B-Cell Prolymphocytic Leukemia

Turkish Journal of Haematology
Hematology
2018English

Targeting of B-Cell Receptor Signalling in B-Cell Malignancies

Journal of Internal Medicine
Internal Medicine
2017English

B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

Targeting the B Cell Receptor Pathway in Chronic Lymphocytic Leukemia

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2012English

Role ofEgr-1Gene Expression in B Cell Receptor-Induced Apoptosis in an Immature B Cell Lymphoma

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1997English

Chronic Active B-Cell-Receptor Signalling in Diffuse Large B-Cell Lymphoma

Nature
Multidisciplinary
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy